Fundraising Fox

64x

1 known investors

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics. The company uses massively parallelized screening and computational insights to engineer high-yield cell lines and production technologies that accelerate the manufacturing of next-generation medicines.

BiotechDeep TechMedical Devices

Investors · 1

BoxGroupNew York · $1M

In the news

Biotech founders are turning to new VCs to raise their seed funding rounds. These are the top 19 investment firms you need to know for early-stage investing.businessinsider.com · Mar 202264x Bio bags $55m to drive cell production tech - BioProcess Insiderbioprocessintl.com · Jan 2022Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech | Fierce Pharmafiercepharma.com · Jan 2022Pitch Deck: 64x Bio Raises $55 Million for Cell, Gene Therapy Tools. - Business Insiderbusinessinsider.com · Jan 202264x Bio Raises $55M in Series A Financingfinsmes.com · Jan 202264x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturingbusinesswire.com · Jan 2022

Frequently asked questions

What does 64x do?
64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics. The company uses massively parallelized screening and computational insights to engineer high-yield cell lines and production technologies that accelerate the manufacturing of next-generation medicines.
Who are 64x's investors?
64x's investors include BoxGroup.